International Summit on Diabetes October 07-08, 2020 Barcelona, Spain

Diabetes Research in Clinical Practice

Novel helpful targets accessible for diabetes incorporates Incretion based treatments, oral remedial specialists like secretagogues, beta cell recovery and expansion and foundational microorganism treatments. Early stage immature microorganism and fatal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the abovementioned, different computational methodologies in Diabetes the executives control have been presented as of late which are assuming a significant job in distinguishing proof of qualities causing diabetes helping in Early Detection of Diabetes. These procedures are additionally valuable in contemplating the substance etioslogies of Diabetes revealing different treatment prospects and model development forms for endurance expectation.

• Updates of anti-diabetic agents
• Incretin based therapies
• Oral therapies: secretagogues
• Diabetes and cancer
• Non-invasive diagnostic tool for detecting cardiovascular disease in diabetes
• Diabetes Case Reports
• Measurement of insulin resistance and secretion in diabetes clinic
• Novel agents in treatment

Recommended Sessions

Related Journals

Are you interested in